SCHEMBL21053205

SCHEMBL21053205

CCOC(=O)CC(=O)C1CC(c2c(F)cccc2F)CN1C(=O)O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
NLRP3 Q96P20 1/20 0.40
ALDH1A1 P00352 6/20 0.36
KDM4E B2RXH2 4/20 0.36
HCRTR2 O43614 3/20 0.35
SMN1; SMN2 Q16637 3/20 0.34
TSHR P16473 2/20 0.34
POLB P06746 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 4/20 0.34
MEN1 O00255 2/20 0.34
ATM Q13315 1/20 0.34
MAPK1 P28482 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALOX15 P16050 1/20 0.33
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28434356 1.00 NLRP3 (0.40) NLRP3ALDH1A1KDM4EHCRTR2SMN1; SMN2
SCHEMBL23455095 0.90 HCRTR2 (0.36) NLRP3ALDH1A1HCRTR2GAA
SCHEMBL21052694 0.90 HCRTR2 (0.36) NLRP3ALDH1A1HCRTR2GAA
SCHEMBL21052695 0.86 TNF (0.32) NLRP3ALDH1A1GAA
SCHEMBL28430316 0.86 TNF (0.32) NLRP3ALDH1A1GAA
SCHEMBL23454922 0.86 MEN1 (0.39) NLRP3ALDH1A1KDM4EPOLBL3MBTL1
SCHEMBL23454923 0.86 MEN1 (0.39) NLRP3ALDH1A1KDM4EPOLBL3MBTL1
SCHEMBL23454921 0.86 MEN1 (0.39) NLRP3ALDH1A1KDM4EPOLBL3MBTL1
SCHEMBL21053552 0.86 ALDH1A1 (0.34) ALDH1A1KDM4ESMN1; SMN2TSHRPOLB
SCHEMBL21052749 0.86 ALDH1A1 (0.34) NLRP3ALDH1A1KDM4EHCRTR2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3720856-A1 DOPAMINE-& X392;-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2020-10-14 EP disclosed
WO-2019112457-A1 DOPAMINE-Β-HYDROXYLASE INHIBITORS BIAL - PORTELA & Cª, S.A. (PT) 2019-06-13 WO disclosed